Chloride conductance and genetic background modulate the cystic fibrosis phenotype of ΔF508 homozygous twins and siblings

Journal of Clinical Investigation

Volumn 108, Issue 11, 2001, Pages 1705-1715

  Bronsveld, I ^a   Mekus, F ^a   Bijman, J ^a   Ballmann, M ^a   De Jonge, H R ^a   Laabs, U ^a   Halley, D J ^a   Ellemunter, H ^a   Mastella, G ^a   Thomas, S ^a   Veeze, H J ^a   Tummler B ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' DIISOTHIOCYANATOSTILBENE 2,2' DISULFONIC ACID; CHLORIDE CHANNEL; CHLORIDE ION; CYCLIC AMP; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADULT; ARTICLE; CHILD; CHLORIDE CONDUCTANCE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE SEVERITY; DIZYGOTIC TWINS; FEMALE; HOMOZYGOSITY; HUMAN; INTESTINE EPITHELIUM; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; SIBLING;

EID: 0035213684     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI12108     Document Type: Article

References (50)

1. Cystic fibrosis
2. Generation of cAMP-activated chloride currents by expression of CFTR
3. Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR)
4. Identification of the cystic fibrosis gene: Genetic analysis
5. Population variation of common cystic fibrosis mutations
6. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis
7. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis
8. Mislocalization of deltaF508 CFTR in cystic fibrosis sweat gland
9. Relationship of a non-cystic fibrosis transmembrane conductance regulator-mediated chloride conductance to organ-level disease in Cftr(-/-) mice
10. Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor
11. Determinants of mild symptoms in cystic fibrosis patients: Residual chloride secretion measured in rectal biopsies in relation to the genotype
12. Residual chloride secretion in intestinal tissue of ΔF508 homozygous twins and siblings with cystic fibrosis
13. Correlation between nasal potential difference measurements, genotype and clinical condition in patients with cystic fibrosis
14. - channel proteins
15. Molecular cloning and transmembrane structure of hCLCA2 from human lung, trachea, and mammary gland
16. Chloride channels in the apical membrane of normal and cystic fibrosis airway and intestinal epithelia
17. ΔF508 CFTR protein expression in tissues from patients with cystic fibrosis
18. Expression of delta F508 cystic fibrosis transmembrane conductance regulator protein and related chloride transport properties in the gallbladder epithelium from cystic fibrosis patients
19. Extreme discordant sib pairs for mapping quantitative trait loci in humans
20. Mapping quantitative trait loci with extreme discordant sib pairs: Sampling considerations
21. Locating human quantitative trait loci: Guidelines for the selection of sibling pairs for genotyping
22. Optimal selection of sib pairs from random samples for linkage analysis of a QTL using the EDAC test
23. Twin studies in medical research: Can they tell us whether diseases are genetically determined?
24. Efficiency of two different nine-loci short tandem repeat systems for DNA typing purposes
25. On the potential of simple repetitive DNA for fingerprinting in clinical, forensic, and evolutionary dynamic studies
26. Rapid non-radioactive detection of the major cystic fibrosis mutation
27. Categories of ΔF508 cystic fibrosis twin and sibling pairs with distinct phenotypic characteristics
28. Physical growth of Swiss children from birth to Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development
29. Changes in the normal maximal expiratory flow-volume curve with growth and aging
30. Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis
31. Factors associated with poor pulmonary function: Cross-sectional analysis of data from the ERCF. European Epidemiologic Registry of Cystic Fibrosis. Roche report
32. In vivo nasal potential difference: Techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis
33. + channel is made of three homologous subunits
34. Regulation of transepithelial ion transport and intracellular calcium by extracellular ATP in human normal and cystic fibrosis airway epithelium
35. Ion transport abnormalities in rectal suction biopsies from children with cystic fibrosis
36. Arachidonic acid metabolites and chloride secretion in rabbit distal colonic mucosa
37. Mechanism of chloride secretion induced by carbachol in a colonic epithelial cell line
38. Forskolin stimulates adenylate cyclase in human colonic crypts: Interaction with VIP
39. Both CFTR and outwardly rectifying chloride channels contribute to cAMP-stimulated whole cell chloride currents
40. The secretory actions of histamine in rat small intestine
41. CFTR and differentiation markers expression in non-CF and delta F508 homozygous CF nasal epithelium
42. Turnover of the cystic fibrosis transmembrane conductance regulator (CFTR): Slow degradation of wild-type and delta F508 CFTR in surface membrane preparations of immortalized airway epithelial cells
43. Chloride conductance expressed by delta F508 and other mutant CFTRs in Xenopus oocytes
44. A mouse model for the cystic fibrosis ΔF508 mutation
45. In vivo activation of the cystic fibrosis transmembrane conductance regulator mutant ΔF508 in murine nasal epithelium
46. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis
47. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis
48. Aerosolized amiloride: Dose effect on nasal bioelectric properties, pharmacokinetics, and effect on sputum expectoration in patients with cystic fibrosis
49. Pulmonary disease severity in men with ΔF508 cystic fibrosis and residual chloride secretion
50. Electrolyte transport in normal and CF epithelia